CN114767664A

CN114767664A - Dry powder medicine for treating novel coronavirus

Info

Publication number: CN114767664A
Application number: CN202210381435.XA
Authority: CN
Inventors: 李明信
Original assignee: Individual
Current assignee: Individual
Priority date: 2022-04-12
Filing date: 2022-04-12
Publication date: 2022-07-22

Abstract

The invention discloses a dry powdery medicament for treating novel coronavirus, which is prepared by drying, grinding, stirring and mixing traditional Chinese medicines and western medicines, wherein the traditional Chinese medicines comprise liquorice and cane sugar, the western medicines comprise a sedative, an anthelmintic, medicinal cereal flour and a bactericide, and the traditional Chinese medicines and the western medicines respectively account for 30% and 70% of the total weight, and are respectively calculated by weight parts, 20 g of liquorice, 10 g of cane sugar, 5 g of sedative, 40 g of anthelmintic, 10 g of medicinal cereal flour and 15 g of bactericide. The medicine is formed by grinding, stirring and mixing traditional Chinese medicines and western medicines, is treated in a mode of oral inhalation and nasal inhalation, is directly affected along with respiration, is particularly suitable for patients infected with the novel coronavirus and asymptomatic infected persons, is used for discovering patients who are not subjected to any repeated positive after healing by tracking diseases caused by the medicine, generates a large amount of antibodies used for immunizing the novel coronavirus in the bodies of the patients, greatly improves the immunocompetence of the patients, and greatly reduces the risk of secondary infection.

Description

Dry powder medicine for treating novel coronavirus

Technical Field

The invention relates to the field of medicines, in particular to a dry powder medicine for treating novel coronavirus.

Background

The global prevalence has been around for three years and has no diminishing momentum, seriously harms people's health and hinders the development of global economy, and the common people suffer from the double stress of physical and life during this new crown virus epidemic. At present, through years of research and exploration, a plurality of vaccines are developed in China, at present, the third-needle vaccination is widely developed in China, and a good new coronavirus prevention effect is obtained, but people still focus on the research of new coronavirus treatment so as to obtain better and faster prevention and treatment effects.

Disclosure of Invention

The invention provides a dry powder medicament for treating novel coronavirus, which is prepared by grinding, stirring and mixing traditional Chinese medicines and western medicines, wherein the medicament is actively sucked by mouth and nasal inhalation, and the powder is passively treated, so that the medicament directly reaches a respiratory tract system firstly infected by the novel coronavirus along with respiration and directly reaches a focus, and the medicament is particularly suitable for gas storage infected persons and asymptomatic infected persons and has obvious curative effect.

A dry powder medicine for treating novel coronavirus is prepared by drying, grinding, stirring and mixing traditional Chinese medicine and western medicine, wherein the traditional Chinese medicine comprises Glycyrrhrizae radix and sucrose, the western medicine comprises sedative, anthelmintic, medicinal cereal flour and bactericide, and the traditional Chinese medicine and the western medicine respectively account for 30% and 70% of the total amount.

Preferably, the weight portions of the liquorice are 15 to 25 g and the sucrose is 5 to 15 g.

Preferably, the technical scheme is that the composition comprises, by weight, 3-8 g of a sedative, 35-45 g of an anthelmintic, 7-12 g of medicinal cereal flour and 10-20 g of a bactericide.

Preferably, the technical scheme comprises 20 g of liquorice, 10 g of cane sugar, 5 g of sedative, 40 g of anthelmintic, 10 g of medicinal cereal powder and 15 g of bactericide in parts by weight.

Preferably, the licorice and the sucrose are ground, respectively sieved by a 100-mesh sieve, and then mixed.

Preferably, the sedative, the anthelmintic, the medicinal cereal flour and the bactericide are ground, respectively sieved by a 80-mesh sieve and then mixed.

Preferably, the mixed powder of the traditional Chinese medicine and the western medicine is sieved by a 180-mesh sieve and then is subpackaged.

As the optimization of the technical scheme, the medicinal cereal powder adopts organic starch.

The invention has the beneficial effects that:

the medicine is prepared by grinding, stirring and mixing traditional Chinese medicines and western medicines, is taken in a way of mouth inhalation and nasal inhalation, directly reaches a respiratory tract system infected by the novel coronavirus along with respiration, directly reaches a focus, is particularly suitable for gas storage infected persons and asymptomatic infected persons, and has remarkable curative effect. In addition, by tracking a large number of patients treated by the medicine, no patient with recurrent yang is found after the disease is cured, and a large number of antibodies for immunizing novel coronavirus are generated in the patient body through detection, so that the immunity of the patient is greatly improved, and the risk of secondary infection is greatly reduced.

Detailed Description

The technical solution of the present invention is clearly and completely described below. All other embodiments, which can be derived by a person skilled in the art from the embodiments of the present invention without any inventive step, are within the scope of the present invention.

A dry powder medicine for treating coronavirus is prepared from Chinese medicinal materials including radix Glycyrrhizae and sucrose, and western medicines including sedative, anthelmintic, medicinal cereal flour and bactericide by drying, grinding, stirring, and mixing, wherein the Chinese medicinal materials and western medicines account for 30% and 70% of the total weight.

In the embodiment, the weight portions of the liquorice are 15 to 25 g, and the sucrose is 5 to 15 g.

In the embodiment, by weight, 3-8 g of sedative, 35-45 g of anthelmintic, 7-12 g of medicinal cereal flour and 10-20 g of bactericide are added.

In the embodiment, by weight, 20 g of liquorice, 10 g of cane sugar, 5 g of sedative, 40 g of anthelmintic, 10 g of medicinal cereal powder and 15 g of bactericide are counted.

In this example, the licorice and sucrose were ground and sieved through 100 mesh sieves, respectively, and then mixed.

In this example, the sedative, anthelmintic, medicinal cereal flour, and antiseptic were ground and sieved through 80 mesh sieves, respectively, and then mixed.

In this embodiment, the mixed powder of the traditional Chinese medicine and the western medicine is sieved by a 180-mesh sieve and then is subpackaged.

In this example, the medicinal cereal flour was an organic starch.

The specific medicine for treating the new coronavirus is a dry powder medicine mixed by Chinese medicines and western medicines, adopts an oral administration mode of oral inhalation to directly reach a respiratory tract system of a human body, has obvious effect, selects and uses 20 g of liquorice, 10 g of cane sugar, 5 g of a sedative, 40 g of an anthelmintic, 10 g of medicinal cereal powder and 15 g of a bactericide as standard dosage of the medicine, can be bagged by adopting 0.1 g/0.2 g/0.25 g/0.3 g/0.4 g of the medicine, and has the specific dosage modes of different age groups: the medicine is taken at a dosage of 1 time a week, wherein the dosage is 0.1 g/time below one year old, 0.2 g/time below 1-2 years old, 0.25 g/time below 2-3 years old, 0.3 g/time below 3-6 years old and 0.4 g/time above 6 years old, the medicine has particularly obvious effect on initial patients and asymptomatic infected persons, can quickly improve symptoms, and has negative detection of new crowns of patients after virus is killed. Because the respiratory tract is soft tissue, the bacteria are living bodies, the bactericidal powder is solid, the viruses and the harmful bacteria are put together and are combined into a whole, and the living bodies can be changed into the solid as long as the living bodies are the viruses, thereby achieving the purpose of isolating the growth environment of the bacteria and finally leading the living viruses and the harmful bacteria to die. The Chinese and western medicine mixed medicine is respiratory tract 'one-time sucking powder': bacteria are infected in the trachea; injecting and infusing in blood vessels; taking medicine in esophagus; is not related to bacteria; a powder suction inlet pipe is used; and killing all kinds of bacteria completely.

The medicament is prepared by grinding, stirring and mixing traditional Chinese medicines and western medicines, is different from the traditional treatment mode of generally adopting injection and atomization agent for treating respiratory diseases, is used for treating respiratory diseases in a mode of oral inhalation and nasal inhalation, directly reaches a focus along with the respiratory system which is directly infected by the novel coronavirus, is particularly suitable for initial infected persons and asymptomatic infection or influenza patients, and has obvious curative effect. In addition, by tracking a large number of patients treated by the medicine, no patient with recurrent yang is found after the disease is cured, and a large number of antibodies for immunizing novel coronavirus are generated in the patient body through detection, so that the immunity of the patient is greatly improved, and the risk of secondary infection is greatly reduced.

The present invention has been described in terms of the preferred embodiment, and it is not intended to be limited to the embodiment. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A drug in dry powder form for use in the treatment of a novel coronavirus, characterized in that: the traditional Chinese medicine composition is prepared by drying, grinding, stirring and mixing traditional Chinese medicines and western medicines, wherein the traditional Chinese medicines comprise liquorice and cane sugar, the western medicines comprise sedatives, anthelmintics, medicinal cereal flour and bactericides, and the traditional Chinese medicines and the western medicines respectively account for 30% and 70% of the total amount.

2. The dry powder medicament for the treatment of a novel coronavirus according to claim 1, characterized in that: according to the weight portion, 15 to 25 g of liquorice and 5 to 15 g of cane sugar.

3. The dry powder medicament for the treatment of a novel coronavirus according to claim 2, characterized in that: 3-8 g of sedative, 35-45 g of anthelmintic, 7-12 g of medicinal cereal flour and 10-20 g of bactericide.

4. The dry powder medicament for the treatment of a novel coronavirus according to claim 3, characterized in that: according to the weight portion, 20 g of liquorice, 10 g of cane sugar, 5 g of sedative, 40 g of anthelmintic, 10 g of medicinal cereal powder and 15 g of bactericide.

5. The dry powder medicament for the treatment of a novel coronavirus according to claim 2, characterized in that: and grinding the liquorice and the cane sugar, respectively sieving the grinded liquorice and the cane sugar by a 100-mesh sieve, and then mixing the grinded liquorice and the cane sugar.

6. The dry powder medicament for the treatment of a novel coronavirus according to claim 3, characterized in that: the sedative, the anthelmintic, the medicinal cereal powder and the bactericide are ground, respectively sieved by a 80-mesh sieve and then mixed.

7. The dry powder medicament for the treatment of a novel coronavirus according to claim 5 or 6, characterized in that: and sieving the mixed traditional Chinese medicine and western medicine powder with a 180-mesh sieve, and then subpackaging.

8. The dry powder medicament for the treatment of a novel coronavirus according to claim 1, characterized in that: the medicinal cereal powder is organic starch.